Prolonged Survival Using First-Line Pazopanib in a Filipino Male with Renal Cell Carcinoma and Brain Metastasis: A Case Report
Renal cell carcinoma is one of the leading causes of cancer worldwide. Brain metastasis is a poor prognostic factor among patients with this disease. The advancements in understanding of the molecular framework behind malignancy and brain metastasis led to more sophisticated treatment regimens which...
Enregistré dans:
Auteurs principaux: | Christianne V. Mojica, Gerard Vincent A. Aguas, Gerardo Thomas H. Cornelio, Ludwig F. Damian |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Karger Publishers
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fcab449b558a40d2a792087ebcf71d57 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Intra-Tumoral Pharmacokinetics of Pazopanib in Combination with Radiotherapy in Patients with Non-Metastatic Soft-Tissue Sarcoma
par: Laura Molenaar-Kuijsten, et autres
Publié: (2021) -
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
par: Eijiro Shimada, et autres
Publié: (2021) -
Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
par: Sareshma Sudhesh Dev, et autres
Publié: (2021) -
Treatment and Outcome of Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation: A Single-Center, Real-World Analysis of Retrospective Data
par: Florian Janisch, et autres
Publié: (2021) -
Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?
par: Paula Aldaz, et autres
Publié: (2021)